Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Trimi vs Dr. Gillis' Wellness Center

Two GLP-1 desks, one scoreboard. We put Trimi and Dr. Gillis' Wellness Center head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 2 · Grade B+

Trimi

Visit Trimi Full brief →
vs
No. 103 · Grade C

Dr. Gillis' Wellness Center

Visit Dr. Gillis' Wellness Center Full brief →

The verdict

Trimi takes this head-to-head.

Trimi scores 89 to 72 on our six-factor Brief Score — A clean, all-in membership desk that publishes one price on both molecules nationwide and hasn't played the teaser-rate game.

That doesn't make Dr. Gillis' Wellness Center a bad call — it's best for patients wanting sublingual odt glp-1 tablets or a needle-free weight-loss option. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
90
36
Supply Reliability
89
76
Transparency
91
88
Access Breadth
89
86
Clinical Oversight
88
84
Track Record
84
78
TrimiBrief Score 89 · 72Dr. Gillis' Wellness Center

Price, coverage & the tracker

TrimiDr. Gillis' Wellness Center
Brief Score89/100 (B+)72/100 (C)
Semaglutide$196/moFrom $149/mo (starting dose, compounded)
Tirzepatide$296/moNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

Trimi: Membership rate held flat this cycle — both molecules disclosed up front, no first-month teaser.

Dr. Gillis' Wellness Center: New to the tracker on 1 August 2026. The published line reads From $149/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.